mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.001 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.002 |